The overarching goal of this study is to develop and examine the feasibility of a music-listening intervention that can be deployed in "real time" to regulate emotions and reduce momentary stress among young adults within the first 12 months of recovery from alcohol use disorder. The investigators design the study with two phases to address three aims: Phase I includes the first two aims. For Aim 1, the investigators will conduct formative research with a sample of young adults who have are within 12 months of recovery (N = 30) to identify features of music selections that are most effective in reducing momentary stress in real-world, ambulatory settings. For Aim 2, the investigtors will focus on developing mobile health technology that uses passive sensing and machine learning to automatically predict moments of heightened stress in real-time and suggest specific musical selections when stress is detected. During Phase II (Aim 3), the investigators will test the feasibility of a novel music-listening intervention among a second unique sample of young adults who are within 12 months of recovery from AUD (N = 30). This protocol refers only to Phase II of the larger study.
Age range
18 Years – 35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Skin Conductance Response (SCR) Rate
Timeframe: Assessed during the 14-day ambulatory assessment phase
Skin Conductance Response (SCR) Amplitude
Timeframe: Assessed during the 14-day ambulatory assessment phase
Skin Conductance Response (SCR) Rise Time
Timeframe: Assessed during the 14-day ambulatory assessment phase
Skin Conductance Response (SCR) Decay Time
Timeframe: Assessed during the 14-day ambulatory assessment phase
Skin Conductance Response (SCR) Width
Timeframe: Assessed during the 14-day ambulatory assessment phase
Skin Conductance Response (SCR) Area Under the Curve (AUC)
Timeframe: Assessed during the 14-day ambulatory assessment phase
MeanNN
Timeframe: Assessed during the 14-day ambulatory assessment phase
SDNN
Timeframe: Assessed during the 14-day ambulatory assessment phase
RMSSD
Timeframe: Assessed during the 14-day ambulatory assessment phase
pNN50
Timeframe: Assessed during the 14-day ambulatory assessment phase
pNN20
Timeframe: Assessed during the 14-day ambulatory assessment phase
CVNN
Timeframe: Assessed during the 14-day ambulatory assessment phase
SD1
Timeframe: Assessed during the 14-day ambulatory assessment phase
SD2
Timeframe: Assessed during the 14-day ambulatory assessment phase
SD1/SD2
Timeframe: Assessed during the 14-day ambulatory assessment phase
Music Listening History
Timeframe: Assessed during the 14-day ambulatory assessment phase